Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021	May 31, 2020
Market Capitalization	259	172	241	291	351	311
Market Cap Growth	-15.12%	-28.69%	-17.27%	-17.12%	12.76%	13.27%
Enterprise Value	384	305	395	424	566	515
Last Close Price	6.99	5.62	7.94	9.87	11.97	10.67
PE Ratio	-	14.29	-	-	-	-
Forward PE	-	25.55	-	-	-	22.02
PS Ratio	1.78	1.34	2.33	2.62	3.48	1.95
PB Ratio	116.11	3.19	6.86	3.31	1.73	1.35
P/TBV Ratio	-	-	-	4.17	2.45	2.52
P/OCF Ratio	96.25	-	-	-	21.32	-
PEG Ratio	-	1.90	1.90	1.90	1.90	1.90
EV/Sales Ratio	2.94	2.37	3.82	3.81	5.61	3.22
EV/EBITDA Ratio	-	260.06	-	29.82	69.55	-
EV/EBIT Ratio	-	-	-	-	192.89	-
Debt / Equity Ratio	2.75	2.42	3.21	1.71	1.07	0.97
Debt / EBITDA Ratio	-	77.92	-	9.63	21.03	31.98
Asset Turnover	0.54	0.51	0.39	0.29	0.19	0.30
Inventory Turnover	2.34	2.14	1.96	1.46	0.96	2.05
Quick Ratio	1.26	1.02	1.23	0.22	0.42	0.47
Current Ratio	2.71	2.09	2.39	0.66	1.46	0.96
Return on Equity (ROE)	-83.58%	20.97%	-104.52%	-10.65%	-10.80%	-8.73%
Return on Assets (ROA)	-3.10%	-1.77%	-4.67%	-0.55%	0.35%	-1.10%
Return on Capital (ROIC)	-4.13%	-2.71%	-6.39%	-0.65%	0.42%	-1.33%
Return on Capital Employed (ROCE)	-	-	-	-	0.70%	-
Earnings Yield	-19.09%	7.00%	-41.36%	-40.11%	-9.20%	-12.26%
FCF Yield	-4.20%	-10.56%	-16.17%	-18.05%	-2.49%	-14.04%
Buyback Yield / Dilution	-9.14%	-22.36%	-1.67%	-0.59%	-0.45%	-1.94%

Updated Jan 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q